Federal Grant to Fund Inhaled Vaccines
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
Read MoreNew research demonstrates that human lung tissue models can sustain immune cells for months and mount targeted responses to respiratory viruses.
Read MoreResearchers designed an automated acoustic monitoring tool that flags indoor coughing without identifying individual patients.
Read MoreA new study finds individual viruses drive specific lung conditions while combined viral spread mirrors total hospital demand.
Read MoreThe United States is “closely monitoring” reports of pneumonic plague in Eastern Russia that may have led to the death of a lab worker.
Read MoreNew clinical recommendations from the American Academy of Pediatrics help healthcare providers identify, diagnose, and care for infants exposed to measles.
Read MoreHarvard researchers discovered the cellular mechanism that allows human cells to identify invading viruses and initiate an immune defense within one hour of infection.
Read MoreStudy shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).
Read MoreOctober is RSV Awareness Month, and the American Lung Association is promoting an educational initiative highlighting the threat of severe illness and hospitalization in older Americans.
Read MorePennsylvania state health officials report nearly 20% of people infected with measles have required hospital care.
Read MoreSudden unexpected infant death accounts for more than one-third of the infant mortality disparity between Black and white infants in the US.
Read MoreA fourth measles death in Pennsylvania comes as the state’s outbreak is now the worst in the United States.
Read MoreA new international initiative aims to provide countries with equitable, rapid access to vaccines during mpox disease surges.
Read MorePennsylvania health officials have reported another measles-related death in an unvaccinated adult woman. It is the state’s third reported death related to the virus.
Read MoreThe World Health Organization warns that cross-border spread, regional security challenges, and funding shortfalls continue to threaten global poliovirus eradication targets.
Read MoreOver 1,000 deaths have been reported in Bangladesh as a measles outbreak has gripped the country since March 2026.
Read MoreLess than 44% of people in the US received a flu shot during the 2025-2026 season, down from 52% in 2021.
Read MoreClassroom dust containing elevated levels of Streptomyces and Mycobacterium species is associated with measurable reductions in lung function among school-aged children.
Read MoreLeading medical societies warn that proposed changes and funding delays at the National Institutes of Health could disrupt active studies and patient care.
Read MoreThe discovery of sorting nexin 5 provides insight into how the body signals infection and manages tissue damage.
Read MoreAAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, alongside updated infant COVID-19 vaccination recommendations.
Read MoreNew clinical recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines for individuals with weakened immune systems.
Read MoreFDA will review Enflonsia’s ability to protect high-risk children under 2 years of age during their second RSV season.
Read MoreA clinical trial will evaluate a weekly dry powder nasal spray’s ability to boost natural defenses and prevent asthma infections.
Read More